{"SPADE_N_05863": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_05863", "Peptide Name": "P3 (bovine cathelicidin, cattle, ruminant, mammals, animals)", "Source": "Bos taurus (Bovine)", "Family": "Belongs to the globin family.", "Gene": "HBA", "Sequence": "VNFKLLSHSLLVTLASHL", "Sequence Length": 18, "UniProt Entry": ["http://www.uniprot.org/uniprot/P01966"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal"], "Target Organism": "[Ref.25753638] Gram-positive bacteria :Staphylococcus aureus ATCC29213 (MIC=25 μg/ml), Clinical Staphylococcus aureus (MIC=12.5 μg/ml);Gram-negative bacteria :Escherichia coli ATCC25922 (MIC=12.5 μg/ml), Clinical Escherichia coli (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=25 μg/ml);Fungi :Candida albicans Clinical strain (MIC=25 μg/ml), Candida albicans ATCC 90029 (MIC=50 μg/ml)", "Hemolytic Activity": "[Ref.25753638] 3% hemolysis at 50 μg/ml , 5% hemolysis  at 100 μg/ml , 7% hemolysis at 200 μg/ml , 7.5% hemolysis at 300 μg/ml , 8% hemolysis at 400 μg/ml against human red blood cells", "Cytotoxicity": "[Ref.25753638] The cell viability of HaCaT cell lines is 93% and 94% at peptide concentrations of 200 and 400 μg/ml. In kumning mice, the LD50 of P3 is 160 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. No mortality w", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C93H154N24O24", "Mass": 1992.36, "PI": 8.74, "Net Charge": 3, "Hydrophobicity": 1.05, "Half Life": "Mammalian:100 hourYeast:>20 hourE.coli:>10 hour", "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans", "Literature": [{"Title": "Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model", "Pubmed ID": "25753638", "Reference": "Antimicrob Agents Chemother. 2015 May;59(5)2835-41. doi 10.1128/AAC.04932-14.", "Author": "Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25753638"}], "Frequent Amino Acids": "LSH", "Absent Amino Acids": "CDEGIMOPQRUWY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 10, "Polar Residues": 11, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_10015", "Similarity": 1.0, "Sequence": "LDDLPGALSELSDLHAHKLRVDPVNFKLLSHSL"}, {"SPADE_ID": "SPADE_N_10016", "Similarity": 1.0, "Sequence": "VNFKLLSHSLL"}, {"SPADE_ID": "SPADE_N_10017", "Similarity": 1.0, "Sequence": "TKAVEHLDDLPGALSELSDLHAHKLRVDPVNFKLLSHSLL"}]}}}